England Nears Historic Win: Hepatitis C Elimination Within Reach by 2030

Context mode is active. Hover over any highlighted term to see its definition. Click a nested term to go deeper.
England is on the verge of making global health history, with health officials announcing the nation is firmly on track to eliminate Hepatitis C as a public health threat by 2030, a major achievement driven by a decade-long, pioneering treatment program. Over 100,000 people have received life-saving antiviral drugs since 2015, resulting in a significant 36% reduction in deaths from the virus over the last ten years. This puts England among the first countries globally to exceed the World Health Organization's benchmark of treating 80% of all known cases. The widespread rollout of highly effective direct-acting antiviral (DAA) medications, capable of curing over 95% of cases within 8 to 12 weeks, has been central to this success. The NHS England program, backed by landmark deals with pharmaceutical companies like Gilead Sciences, MSD, and AbbVie, has focused on expanded testing initiatives, including A&E blood tests, GP registration testing, and confidential at-home kits, particularly targeting vulnerable groups such as people who inject drugs and those from certain Eastern European countries who might have been exposed to the virus before stricter medical sterilization standards. Though the national aim was initially 2025, reaching the global 2030 target remains a monumental step, especially as around 50,200 adults were still estimated to be living with chronic Hepatitis C in England in 2024. Looking ahead, sustaining this momentum requires continued commitment to finding the remaining undiagnosed cases and ensuring equitable access to treatment, especially for the hardest-to-reach populations. A national patient management system, planned for 2026-27, aims to track progress more robustly, and ongoing efforts are focusing on increasing diagnosis and care for Hepatitis B, as full 'viral hepatitis elimination' encompasses both. The success in England offers a vital blueprint for other nations working towards the WHO ambitious 2030 global elimination goals.